I study innovation, competition and regulation in the pharmaceutical market.
Assistant Professor of Health Care Policy, Harvard Medical School
I have been at the Department of Health Care Policy at Harvard Medical School since 2022. Before that, I was an Assistant Professor of Economics at the University of North Carolina at Chapel Hill. I received a BA in Economics and a BS in Mathematics from the University of Chicago in 2011, and a PhD in Economics from Harvard University in 2018.
Latest news
- Jul 2026 “The effect of market size on pharmaceutical innovation” out in Health Affairs Scholar.
- Jun 2026 Joined the Stigler Center at the University of Chicago as an Affiliate Fellow.
- May 2026 “Substitutes for Success?” out in the Journal of Economic Perspectives.
- May 2026 “Biosimilar Entry and the Pricing of Biologic Drugs” published online at the Review of Industrial Organization.
More news
- May 2026 “Medicaid’s GENEROUS Most-Favored-Nation Pricing Model” out in the New England Journal of Medicine.
- Mar 2026 “Trends in prescription drug coverage restrictions in Medicare, Medicaid, and commercial insurance plans” out in Health Affairs Scholar.
- Nov 2025 “Improved Insurance Coverage Increased Biosimilar Semglee’s Market Share After The FDA’s Interchangeability Designation” out in Health Affairs.
- Sep 2025 “Reference Pricing as a Deterrent to Entry” cited in The Economist.
- Sep 2025 “Medicare Part D Savings Under the Manufacturer Discount Program vs Coverage Gap Discounts” out in JAMA Network Open.